Middle East and Africa Magnetic Resonance Imaging (MRI) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Middle East and Africa Magnetic Resonance Imaging (MRI) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Middle East and Africa MRI Market is expected to grow with a CAGR of 8.1% in the forecast period.

The COVID-19 pandemic is an unprecedented health concern and has significantly impacted the magnetic resonance imaging market in the Middle East & African region. During the first wave of COVID-19 in the Middle East & Africa region, there was a significant reduction in total diagnostic imaging services. The effect of pulmonary tuberculosis (TB) and human immunodeficiency virus (HIV) infection on the clinical course and radiologic characteristics of COVID-19 pneumonia was unknown, according to RSNA International Trends: "A Global Perspective on the COVID-19 Pandemic and Radiology in Late 2020". According to preliminary research, contemporary tuberculosis and human immunodeficiency virus are both separately linked to a rise in COVID-19-related mortality. Lockdowns result in a 70% reduction in elective outpatient services and a 40% reduction in the overall imaging workload. This made the already lengthy wait times for advanced imaging services like MRI and CT much longer. International Finance Corporation 2021 claims that a lot of healthcare professionals in Africa are unable to afford sophisticated medical equipment. Equipment shortages, such as MRI machines and CT scanners, affect African nations. As a result, patients involving post-covid problems required the appropriate diagnostic equipment, including an MRI. Hence, the region may see an increase in demand for MRI.

The rising technological advancement, such as the inclusion of MRI with PET or CT, to provide imaging possibilities with less exposure to harmful radiations is boosting the market growth in the region. The global players, such as GE Healthcare, Siemens, and Philips, have an extensive hold on improving technology, as well as distribution channels in the region. By 2050, the number of people with dementia was expected to have nearly tripled to more than 152 million, according to statistics presented at the Alzheimer's Association International Conference in 2021. The Middle East, North Africa, and Eastern Sub-Saharan Africa are predicted to experience the largest increases in prevalence. Therefore, one of the key factors influencing Alzheimer's disease and related research is the increased incidence of dementia. This is anticipated to fuel the development of very high field MRI scanners in the area, which will fuel the expansion of this market in the Middle East & Africa. Additionally, according to a study published in Frontiers in Neurology in March 2021 titled "Dominant and Modifiable Risk Factors for Dementia in Sub-Saharan Africa (SSA): A Systematic Review and Meta-Analysis," the annual incidence of clinically diagnosed dementia in SSA was estimated to be 2%, with a prevalence of 5%. The most significant modifiable factor in the current study was low educational attainment, while older age was the most significant risk factor for dementia. As a result, the market growth is anticipated to be further fueled by the increasing frequency of dementia with a clinical diagnosis, as the research calls for very high field MRI scanners. Thus, the abovementioned factors are expected to increase market growth.

However, the high cost of MRI is expected to hinder market growth.

Key Market TrendsOncology Segment is Expected to Show Significant Growth During the Forecasted Years

Factors such as the increasing prevalence of cancer coupled with research studies are expected to increase market growth in the future. The oncology segment deals with the diagnosis and treatment of tumors and cancers. According to GLOBOCAN 2020, an estimated 28,704 new cancer cases were reported in Israel, and 27,885 new cancer cases were reported in Saudi Arabia in the year 2020. Thus, with the rising incidence of cancer, the magnetic resonance imaging market in Middle East & Africa region is estimated to witness healthy growth over the forecasted period. According to a research paper published in March 2022 titled "Cancer Burden Among Arab-World Females in 2020: Working Toward Improving Outcomes," 2.4% of all new cancer cases worldwide, or 463,675 cases, were predicted to occur in Arab nations. 52.9% of that total were malignancies in women, compared to 47.8% globally. Compared to the global average of 186 per 100,000 people, the age-standardized incidence rate (ASIR) for Arab women was 137.7 per 100,000. (WFCs). Therefore, it is anticipated that the increased frequency of cancer among Arab females relative to the global average will spur market expansion.

Similarly, according to a different research study released in April 2022 and titled "Mapping Cancer in Africa: A Comprehensive and Comparable Characterization of 34 Cancer Types Using Estimates From GLOBOCAN 2020," there were an estimated 1.1 million new cases and 711,429 [611,604 - 827,547] deaths from neoplasms in Africa in 2020. In 2020, the age-standardized incidence rate (ASIR), which ranged from 78.4/100,000 (Niger) to 212.5/100,000 (La Réunion), was predicted to be around 132.1/100,000. In Africa, the age-standardized mortality rate (ASMR) was 88.8/100,000, with the Republic of the Congo having the lowest rate at 56.6/100,000 and Zimbabwe having the highest at 139.4/100,000. High cancer rates in Africa necessitate a comprehensive approach to cancer control and management, which may include raising cancer awareness, implementing primary and secondary prevention, reducing risk factors, enhancing infrastructure, and providing timely treatment, among other things. Thus, the abovementioned factors are expected to increase market growth.

South Africa is Expected to Hold Significant Share of the Market Over the Forecast Period

Factors such as the increasing prevalence of diseases, coupled with the increasing geriatric population and research studies are expected to increase the market growth. For instance, South Africa reported 108,168 new instances of cancer in 2020, and 262,455 cancer cases were diagnosed during a five-year period, according to the Globocan 2020 study. The same survey also predicted that by 2040, there will be 175,102 new instances of cancer. The demand for MRI scanners for the detection and diagnosis of cancer/tumor cases is anticipated to rise with the country's rising cancer prevalence. This is anticipated to fuel the country's market's expansion. The burden of chronic diseases is anticipated to rise as the country's geriatric population rises, which is likely to stimulate the development of magnetic resonance imaging. For instance, the United Nations Population Fund's World Population Dashboard's Statistics 2021 shows that in South Africa, 65.8% of the population is between the ages of 15 and 64, while 5.6% of the population is 65 years of age or older. According to a research study titled "Neuroimaging young children and associations with neurocognitive development in a South African birth cohort study" that was published in October 2020, magnetic resonance imaging (MRI) is an essential tool for examining young children's brain development and the neurobiological mechanisms underlying developmental risk and resilience. It is predicted that this will lead to increased use and adoption of MRI systems in the region.

Competitive Landscape

The Middle East and Africa MRI Market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players in the market are Canon Medical Systems Corporation, Esaote SpA, GE Healthcare, Hitachi Ltd. etc

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.